c-Myc and AKT1 positively correlate with PCAT-1 expression in HNSCC. »
04/15/19

EGFR tyrosine kinase inhibitors (TKIs) erlotinib and gefitinib showed superior levels of efficacy. »
04/15/19

RU486 significantly inhibited anti-cytotoxic effect of both GCs. »
04/15/19

Proximal tumor location independently associated with increased risk for local treatment failure. »
04/16/19

Screening for brain metastases could be advisable in NEC patients. »
04/16/19

Intronic and intergenic hotspot regions from 26 genes significantly associated with relapse. »
04/16/19

JDCaP-CR2F exhibited elevated AR-v567es expression resulting from genomic deletion. »
10/17/18

Combination of HE4 and CA125 (i.e. ROMA) achieved an AUC of 91.2%. »
02/26/19

Targeting glutaminolytic glutamate bioavailability effective therapeutic strategy for GRM1-activated tumors. »
05/15/18

Silencing of TESC increased MBD1 expression and decreased H3K4me2/3 level. »
10/25/18